Early Intervention With Almotriptan: Results of the AEGIS Trial (AXERT ^® Early Migraine Intervention Study)

Abstract

Treatment with almotriptan within 1 hour of migraine onset resulted in significantly better clinical outcomes than placebo and tolerability similar to placebo. Acute medications, such as almotriptan, that are both effective and well tolerated may encourage patients to access acute treatment earlier.